期刊文献+

高迁移率蛋白1、Toll受体与动脉粥样硬化的关系

Relationship between High Mobility Group Box 1,Toll-like Receptors and Atherosclerosis
下载PDF
导出
摘要 动脉粥样硬化是血管慢性增殖性炎症过程,也是对血管损伤的反应和修复过程。高迁移率蛋白1作为一种重要的晚期炎症介质,参与多种炎性疾病的发生发展。Toll样受体是最重要的先天免疫系统的模式识别受体识别微生物的病原相关分子模式。高迁移率蛋白1可能通过Toll样受体激活炎性反应,参与动脉粥样硬化的发生和发展。 Atheroselerosis is a vascular chronic inflammatory hyperplastic process, and is also the reaction to blood vessel damage and the healing process. As an important late inflammatory mediator, high mobility group box 1 ( HMGB1 ) is involved in the occurrence and development of various inflammatory diseases. Toll-like receptors ( TLRs ) are the most important pattern-recognition receptors of the innate immune system that recognize pathogen-associated molecular patterns ( PAMPs ) of microbes. HMGB1 may activate the inflammatory reaction through Toll-like receptors, and thereby participate in occurrence and development of atherosclerosis.
作者 曾瑜 李家富
出处 《心血管病学进展》 CAS 2012年第5期667-669,共3页 Advances in Cardiovascular Diseases
基金 四川省省教育厅合作项目 项目编号2006J13-72
关键词 高迁移率蛋白1 TOLL样受体 动脉粥样硬化 high mobility group box 1 Toll-like receptors atherosclerosis
  • 相关文献

参考文献24

  • 1Bianehi ME, Agresti A. HMG proteins: dynamic players in gene regulation and differentiation[J]. Curr Opin Genet Dev,2005 15(5) :496-506.
  • 2Bianchi ME. HMGB1 love pany[J]. J Leukoc Biol,2009,86(3):573- 576.
  • 3Hashimoto T, Ishii J, Kitagawa F, et al. Circulating high-mobility group box 1 and cardiovascular mortality in unstable angina and non-ST-segment elevation myocardial infarction[J]. Atherosclemsis, 2012,221(2) :490-495.
  • 4Scaffidi P, Mistell T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation[ J]. Nature, 2002,418 (6894) : 191-195.
  • 5Rovere-Querini P, Capobianco A, Scaffidi P, et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells[J]. EMBO Rep,2004,5(8) : 825- 830.
  • 6Guggino G, Giardina AR, Ciccia F, et al. Are Toll-like receptors and decoy re- ceptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes [ J] ? Clin Dev Immunol,2012,2012 : 135932.
  • 7Wang YC, Lin S, Yang QW, et al. Toll-like receptors in cerebral ischemic in- flammatory injury [ J ]. J Neuroinflammation ,2011,8 : 134.
  • 8Yang H, Hreggvidsdottir HS, Palmblad K, et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release[ J]. Proc Natl Acad Sci USA ,2010,107(26 ) : 11942-11947.
  • 9Goldstein RS, Gallowitsch-Puerta M, Yang L, et al. Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia [ J ]. Shock,2006,25 (6) : 571-574.
  • 10van Zoelen MA, Laterre PF, van Veen SQ, et al. Systemic and local high mobility group box 1 concentrations during severe infection[ J]. Crit Care Med, 2007,35 ( 12 ) :2799 -2804.

二级参考文献47

  • 1黄庆先,王国斌,孙念峰,王春友.高迁移率族蛋白框1反义核酸抑制人胰腺癌细胞系PCNA-1侵袭的研究[J].癌症,2004,23(9):1036-1040. 被引量:16
  • 2刘道芳,魏伟,宋礼华.TLRs介导的免疫调节信号通路及其药物作用[J].中国药理学通报,2005,21(6):653-656. 被引量:3
  • 3李树合,周定标,袁晓玲,孙同柱,余新光,许百男,卜博,蔡剑鸣.颈动脉粥样硬化不稳定斑块异质性的病理研究及高分辨MRI影像特点分析[J].中华神经外科杂志,2006,22(8):485-488. 被引量:28
  • 4Bianchi ME, Bltrame M. Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia. Embo Rep, 2000, 2: 109-114.
  • 5Yuan F, Gu L, Guo S, et al. Evidence for involvement of HMGBI protein in human DNA mismatch repair. J Biol Chem,2004, 279: 20935-20940.
  • 6Bianchi ME, Manfredi A. Chromatin and cell death. Biochim Biophys Acta, 2004, 1677: 181-186.
  • 7Andersson U, Tracey KJ. HMGBI as a mediator of necrosisinduced inflammation and a therapeutic target in arthritis. Rheum Dis Clin North Am, 2004, 30 : 627- 637.
  • 8Erlandsson Harris H, Andersson U. Mini-review: The nuclearprotein HMGBI as a proinflammatory mediator. Eur J Immunol,2004, 34: 1503-1512.
  • 9Chen G, Ward MF, Sama AE, et al. Extracellular HMGB1 as aproinflammatory cytokine. J Interferon Cytokine Res, 2004, 24:329-333.
  • 10Schmidt AM, Yan SD, Yan SF, et al. The biology of thereceptor for advanced glycation end products and its ligands.Biochim Biophys Acta, 2000, 1498 : 99-111.

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部